The decisions that determine Phase 2 timing are made, or missed, in the first two quarters after the IND opens.
White Paper
IND Ready Is Not Phase 2 Ready
Related Resources
All Resources
post
From Science to Success: Why CQV Is the Missing Link in Advanced Therapy Operational Readiness
Read More
case-study
The Critical Role of CQV Leadership in Achieving GMP-Ready Cell & Gene Therapy Production
Read More
post
Why Human Oversight is the Secret Ingredient in Supply Chain Automation
Read More
post
Key Takeaways from JPM 2026 (What We Heard + What It Means)
Read More
Let's move from science to success.
Let’s Talk